HLZ

1-hydrazinophthalazine

Created:	2010-03-02
Last modified:	2021-03-13

Find Related PDB Entry
3 entries where HLZ is found as a standalone ligand

Help Find related ligands:
Similar Ligands (Stereospecific) Similar Ligands (including Stereoisomers) Similar Ligands (Quick Screen) Similar Ligands (Substructure Stereospecific) Similar Ligands (Substructure including Stereoisomers)

Help

Find related ligands:

Similar Ligands (Stereospecific) Similar Ligands (including Stereoisomers) Similar Ligands (Quick Screen) Similar Ligands (Substructure Stereospecific) Similar Ligands (Substructure including Stereoisomers)

Chemical Details
Formal Charge	0
Atom Count	20
Chiral Atom Count	0
Bond Count	21
Aromatic Bond Count	11

Toggle Hydrogen Toggle Labels

Chemical Component Summary
Name	1-hydrazinophthalazine
Synonyms	Hydralazine; phthalazin-1-ylhydrazine
Systematic Name (OpenEye OEToolkits)	phthalazin-1-ylhydrazine
Formula	C₈ H₈ N₄
Molecular Weight	160.176
Type	NON-POLYMER

Chemical Descriptors
Type	Program	Version	Descriptor
SMILES	ACDLabs	12.01	n2nc(c1ccccc1c2)NN
SMILES	CACTVS	3.370	NNc1nncc2ccccc12
SMILES	OpenEye OEToolkits	1.7.0	c1ccc2c(c1)cnnc2NN
Canonical SMILES	CACTVS	3.370	NNc1nncc2ccccc12
Canonical SMILES	OpenEye OEToolkits	1.7.0	c1ccc2c(c1)cnnc2NN
InChI	InChI	1.03	InChI=1S/C8H8N4/c9-11-8-7-4-2-1-3-6(7)5-10-12-8/h1-5H,9H2,(H,11,12)
InChIKey	InChI	1.03	RPTUSVTUFVMDQK-UHFFFAOYSA-N

Drug Info: DrugBank

DrugBank data are sourced from datasets licensed under a Creative Common's Attribution-NonCommercial 4.0 International License

DrugBank ID	DB01275
Name	Hydralazine
Groups	investigational approved
Description	Originally developed in the 1950s as a malaria treatment, hydralazine showed antihypertensive ability and was soon repurposed.[A186841] Hydralazine is a hydrazine derivative vasodilator used alone or as adjunct therapy in the treatment of hypertension and only as adjunct therapy in the treatment of heart failure.[A186820,L8782,L8785] Hydralazine is no longer a first line therapy for these indications since the development of newer antihypertensive medications.[T691] Hydralazine hydrochloride was FDA approved on 15 January 1953.[L8779]
Synonyms	(2H)-Phthalazinone hydrazone 1-Hydrazinophthalazine (1Z)-1(2H)-Phthalazinone hydrazone 1-Phthalazinylhydrazine Hydrallazine Hydralazine hydrochloride Idralazina Hydralazin Hydralazinum Hydrazone 1(2H)-phthalazinone 6-Hydralazine Hypophthalin Hydralazine Hydrazinophthalazine Hydralazine polistirex Hidralazina Phthalazin-1-ylhydrazine
Brand Names	Apresoline Tablets, 50mg Hydralazine-10 Tab 10mg Jamp-hydralazine Isosorbide dinitrate and hydralazine hydrochloride Novo-hylazin Tab 10mg USP HydrALAZINE hydrochloride Novo-hylazin Tab 50mg Nu-hydral Tab 10mg Hydralazine HCl Apresoline Tablets, 25mg Apresoline hydrochloride Hydralazine Hydrochloride Injection Hydralazine-50 Tab Isosorbide Dinitrate and Hydralazine Hydrochloride Novo-hylazin Tab 25mg PMS-hydralazine Apresoline Tablets, 10mg BiDil hydrALAZINE Hydrochloride Apresoline Nu-hydral Tab 25mg Asn-hydralazine Hydralazine Hydrochloride Injection, USP Hydralazine Apo-hydralazine Ser-AP-ES Tab Ser-Ap-Es Hydralazine Hydrocloride Mint-hydralazine Hydralazine-25 Tab HydrALAZINE Hydrochloride Hydralazine HCl and Hydrochlorothiazide Hydralazine Hydrochloride Nu-hydral Tab 50 mg
Indication	Hydralazine is indicated alone or adjunct to standard therapy to treat essential hypertension.[L8782] A combination product with isosorbide dinitrate is indicated as an adjunct therapy in the treatment of heart failure.[L8785]
Categories	Antihypertensive Agents Antihypertensive Agents Indicated for Hypertension Arteriolar Smooth Muscle, Agents Acting On Arteriolar Vasodilation Arteriolar Vasodilator Cardiovascular Agents Cytochrome P-450 CYP3A Inhibitors Cytochrome P-450 CYP3A4 Inhibitors Cytochrome P-450 CYP3A4 Inhibitors (strength unknown) Cytochrome P-450 Enzyme Inhibitors Direct Vasodilators Drugs that are Mainly Renally Excreted Hydrazinophthalazine Derivatives Hydrazinophthalazine Derivatives and Diuretics Hypotensive Agents Phthalazines Pyridazines Vasodilating Agents
ATC-Code	C02DB02 C02LG02
CAS number	86-54-4

Drug Targets

DrugBank data are sourced from datasets licensed under a Creative Common's Attribution-NonCommercial 4.0 International License

Name	Target Sequence	Pharmacological Action	Actions
Amine oxidase [copper-containing] 3	MNQKTILVLLILAVITIFALVCVLLVGRGGDGGEPSQLPHCPSVSPSAQP...	unknown	inhibitor
Hypoxia-inducible factor 1-alpha	MEGAGGANDKKKISSERRKEKSRDAARSRRSKESEVFYELAHQLPLPHNV...	unknown	inducer
Prolyl 4-hydroxylase subunit alpha-1	MIWYILIIGILLPQSLAHPGFFTSIGQMTDLIHTEKDLVTSLKDYIKAEE...	unknown	inhibitor
Cytochrome P450 3A4	MALIPDLAMETWLLLAVSLVLLYLYGTHSHGLFKKLGIPGPTPLPFLGNI...	unknown	inhibitor
Albumin	MKWVTFISLLFLFSSAYSRGVFRRDAHKSEVAHRFKDLGEENFKALVLIA...	unknown	binder

Drug Info/Drug Targets: DrugBank 3.0: a comprehensive resource for 'omics' research on drugs. Knox C, Law V, Jewison T, Liu P, Ly S, Frolkis A, Pon A, Banco K, Mak C, Neveu V, Djoumbou Y, Eisner R, Guo AC, Wishart DS. Nucleic Acids Res. 2011 Jan; 39 (Database issue):D1035-41. | PMID:21059682